ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Microbiome and Metabolomics in Liver Cancer: Scientific Technology

Ganesan, Raja; Yoon, Sang Jun; Suk, Ki Tae*
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES2023-1DOI: 10.3390/ijms24010537
15被引2阅读
引用收藏
分享

摘要

Primary liver cancer is a heterogeneous disease. Liver cancer metabolism includes both the reprogramming of intracellular metabolism to enable cancer cells to proliferate inappropriately and adapt to the tumor microenvironment and fluctuations in regular tissue metabolism. Currently, metabolomics and metabolite profiling in liver cirrhosis, liver cancer, and hepatocellular carcinoma (HCC) have been in the spotlight in terms of cancer diagnosis, monitoring, and therapy. Metabolomics is the global analysis of small molecules, chemicals, and metabolites. Metabolomics technologies can provide critical information about the liver cancer state. Here, we review how liver cirrhosis, liver cancer, and HCC therapies interact with metabolism at the cellular and systemic levels. An overview of liver metabolomics is provided, with a focus on currently available technologies and how they have been used in clinical and translational research. We also list scalable methods, including chemometrics, followed by pathway processing in liver cancer. We conclude that important drivers of metabolomics science and scientific technologies are novel therapeutic tools and liver cancer biomarker analysis.

学科与关键词

关键词
liver cancermicrobiomemetabolomicsmetabolitesscientific technology
相关
加载中…
  • Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
    Beyoglu, Diren; Idle, Jeffrey R.*Metabolites, 2020, 10(2): 50.被引 56
  • A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry
    Yin, Peiyuan*; Wan, Dafang; Zhao, Chunxia; Chen, Jing; Zhao, Xinjie; Wang, Wenzhao; Lu, Xin; Yang, Shengli; Gu, Jianren; Xu, GuowangMolecular BioSystems, 2009, 5(8): 868-876.被引 195
  • Reprogramming of central carbon metabolism in hepatocellular carcinoma
    Xia, Haoming; Huang, Ziyue; Xu, Yi*; Yam, Judy Wai Ping*; Cui, Yunfu*Biomedicine and Pharmacotherapy, 2022, 153: 113485.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
发表日期
2023-01
卷期
第 24 卷, 第 1 期
页码
537
DOI
10.3390/ijms24010537
语言
ENGLISH
成果收录
SCIE
资助标注
Hallym University Research Fund; National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology; Promotion of Innovative Businesses for Regulation-Free Special Zone - Ministry of SMEs and Startups (MSS, Korea) [NRF-2018M3A9F3020956, NRF-2019R1I1A3A01060447, NRF-2020R1I1A3073530, NRF-2020R1A6A1A03043026]; [P0020622]

作者

  • G

    Ganesan, Raja (第一作者)

  • Y

    Yoon, Sang Jun

查看全部 3 位作者收起作者
  • S

    Suk, Ki Tae (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417